Legend Capital

Legend Capital is a Beijing-based venture capital firm and subsidiary of Legend Holdings. Founded in 2001, it focuses on early-stage and growth investments in technology-driven sectors with operations anchored in China and related markets. The firm backs companies in IT, internet applications and services, outsourcing, IC design and key components, as well as sectors such as telecommunications, media, healthcare, consumer and intelligent manufacturing. It manages multiple funds and actively supports portfolio companies with business development, market positioning and access to Chinese markets to create value. Legend Capital aims to back high-growth ventures and build lasting value in China's venture capital ecosystem.

Daqing Cai

Managing Director

Chen Hao

Managing Director and Head of Investment

Rui Chen

Managing Director

Raymond Chen

Co-Chief Investment Officer

FAN Qihui

Executive Director

Past deals in Computer Vision

X Square

Seed Round in 2025
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Saige Research

Series B in 2023
Saige Research specializes in AI solutions for industrial inspection and quality control. It offers a deep learning vision inspection platform tailored for manufacturers, enhancing inspector efficiency through power detection, speed detection, wide versatility, and convenient development.

Using.AI

Seed Round in 2023
Using.AI is an artificial intelligence application service provider focused on enhancing the advanced manufacturing industry through innovative technology. The company specializes in machine vision, robotics learning, and machine learning to develop self-learning solutions that optimize manufacturing processes. Its products aim to advance sectors such as OLED, optics components, and semiconductor devices, providing significant improvements in efficiency and effectiveness. By leveraging AI, Using.AI delivers cutting-edge solutions that address the evolving needs of the manufacturing landscape.

PolarisIC

Seed Round in 2022
PolarisIC specializes in the development of advanced measurement and imaging chip products, utilizing cutting-edge single-photon avalanche diode (SPAD) technology. The company offers two main product lines: direct photon time-of-flight (dToF) measurement chips and low-light imaging chips. The dToF chips are designed for various applications, including height determination for unmanned aerial vehicles (UAVs), obstacle avoidance, navigation for automated guided vehicles (AGVs), and smart perception in the Internet of Things (IoT). The low-light imaging chips boast high sensitivity and pixel digitization capabilities, with potential uses in night vision systems, security monitoring, industrial measurement, and smartphone photography. PolarisIC is committed to technological innovation, excelling in dToF detection, high-speed digital processing, detection algorithm fusion, and system integration.

Lunit

Venture Round in 2021
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Aqrose Technology

Series B in 2020
Aqrose Technology Co., Ltd., established in 2017 and originating from the AI Lab of Tsinghua University, specializes in integrating advanced artificial intelligence and machine vision technologies into industrial applications. The company develops products such as AIDI, a standardized intelligent industrial vision platform, and AIPICK, an intelligent inspecting and sorting robot that utilizes 3D vision technology. Aqrose's solutions are designed to enhance manufacturing processes and product quality across various sectors, including consumer electronics, automobiles, new energy, medicine, semiconductors, and logistics. Their innovations have been implemented in over 100 factories, serving prominent clients in advanced manufacturing and smart logistics, thereby contributing to increased efficiency and effectiveness in these industries.

Lunit

Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Nanovision

Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base, specializes in high-speed and high-precision radiology imaging solutions. With a significant research and development presence in Yonyou Industrial Park and a subsidiary in Chengdu, the company focuses on static computed tomography (CT), X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision developed China's first self-designed CMOS flat panel detector, known as the Merak series, which serves a diverse range of applications across medical, industrial, and security sectors. By providing advanced technological support both domestically and internationally, Nanovision aims to enhance imaging capabilities in various fields.

Black Sesame Technologies

Series B in 2019
Founded in 2016 with headquarters in Silicon Valley and Shanghai, Black Sesame Technologies specializes in AI digital imaging technology. It develops image/video processing algorithms and related applications for various imaging systems, focusing on embedded sensing platforms for smartphones, autonomous driving, and consumer electronics.

Aqrose Technology

Series A in 2019
Aqrose Technology Co., Ltd., established in 2017 and originating from the AI Lab of Tsinghua University, specializes in integrating advanced artificial intelligence and machine vision technologies into industrial applications. The company develops products such as AIDI, a standardized intelligent industrial vision platform, and AIPICK, an intelligent inspecting and sorting robot that utilizes 3D vision technology. Aqrose's solutions are designed to enhance manufacturing processes and product quality across various sectors, including consumer electronics, automobiles, new energy, medicine, semiconductors, and logistics. Their innovations have been implemented in over 100 factories, serving prominent clients in advanced manufacturing and smart logistics, thereby contributing to increased efficiency and effectiveness in these industries.

Lunit

Series B in 2018
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Renderbus

Series B in 2018
Renderbus provides vertical cloud computing SaaS services for the vision industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.